Plaque PsO
Enbrel® is approved across 6 indications, including paediatric indications.¹
Paediatric plaque PsO
Treatment with Enbrel® in PsO is not associated with significant changes in the levels of triglycerides, HDL, LDL or total cholesterol.2,*
Enbrel®: Demonstrating Efficacy Across the Spectrum of PsO
*Retrospective analysis (n=230) compared with MTX.
†Enbrel® showed significant improvement in PASI scores after 24 weeks.
‡Onset of action seen as early as 12 weeks for etanercept in improving scalp symptoms.
§The recommended dose of Etanercept is 25 mg administered twice weekly or 50 mg administered once weekly.
||Etanercept 50 mg BIW can be used for patients with severe psoriasis for upto 12 weeks followed by 25 mg BIW or 50 mg OW thereafter.
BIW, twice a week; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MTX, methotrexate; OW, otherwise; PASI, Psoriasis Area and Severity Index; PsARC, psoriatic arthritis response criteria; PsO, psoriasis; PUVA, psoralen and ultraviolet-A light; QoL, quality of life.
References:
Please click the Prescribing Information link to view the safety and adverse events information of Enbrel®.
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory.
PP-ENB-IND-0814 August 2022
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Hac habitasse platea dictumst quisque sagittis purus sit amet volutpat. Lectus magna fringilla urna porttitor rhoncus. Venenatis urna cursus eget nunc scelerisque viverra. Id donec ultrices tincidunt arcu non sodales.
Sagittis aliquam malesuada bibendum arcu vitae elementum curabitur. Pellentesque elit ullamcorper dignissim cras tincidunt. Orci ac auctor augue mauris augue neque. Dui vivamus arcu felis bibendum ut tristique et egestas quis. Sed vulputate mi sit amet mauris commodo.
Nunc eget lorem dolor sed viverra ipsum. Sed ullamcorper morbi tincidunt ornare.
These pages are not intended for patients or for members of the general public. The web pages contain promotional content.
If you select 'No', you will be redirected to Pfizer.co.in
For more details on, Who is a Registered medical practitioner*, please visit https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf , Page No. 39, Rule 2 part (ee), last accessed on 26th April 2021.
Address: The Capital, A Wing, 1802, 18th Floor, Plot No. C-70, 'G' Block, Bandra Kurla Complex, Bandra East, Mumbai - 400051.